RPRX PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

RPRX ▲ +6.80% at T+20d

NEUTRAL call ✓ call won +6.80% · α vs SPY +1.43% · entry $50.00 → $53.40

Next anchor: T+60d in 5w

Last close $54.86 (close Jun 8) · +9.72% from $50.00 entry

Entry anchored
Apr 16, 03:59 PM ET
via Databento tick

T+1d

-1.40%

call -1.40% · α -1.21%

$49.30

settled 7w ago

T+5d

-1.24%

call -1.24% · α -1.79%

$49.38

settled 7w ago

T+20d

+6.80%

call +6.80% · α +1.43%

$53.40

settled 26d ago

T+60d

—

call — · α —

—

in 5w

Price Chart

Loading chart...

Executive Summary

Royalty Pharma announced a quarterly dividend of $0.235 per share, payable June 10, 2026, to shareholders of record as of May 15, 2026. This is a routine capital return with no change in dividend policy or magnitude.

Actionable Insight

This is a routine dividend; no strategic shift or financial change is indicated. Traders should monitor for any future adjustments in payout ratio or yield signaling a policy shift.

Key Facts

Royalty Pharma declared a quarterly dividend of $0.235 per Class A ordinary share.
Dividend payable on June 10, 2026, to shareholders of record on May 15, 2026.
No change in dividend amount or policy announced.

Financial Impact

Approximately $138 million quarterly (based on ~587 million shares outstanding and $28B market cap)

dividendcash outflow

Risk Factors

Ongoing insider selling ($1.6M in the last 30 days) may signal muted confidence despite stable dividends.
Pharma royalty models are sensitive to drug lifecycle risk and patent expirations, though not reflected in this filing.

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3276138

12 reports for RPRX

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for RPRX — sortable, filterable
	Type				Now
May 28, 2026 12d ago	Insider Cluster NEUTRAL ★ 4/10	$55.76 $55.87	▲ +0.20%	▲ +2.72%	$54.86 (−1.61%)
May 28, 2026 12d ago	8-K NEUTRAL ★ 4/10	$55.76 $54.97	▼ −1.42%	▼ −1.12%	$54.86 (−1.61%)
May 22, 2026 19d ago	Insider Cluster NEUTRAL ★ 2/10	$54.50 $55.18	▲ +1.25%	▼ −0.41%	$54.86 (+0.66%)
May 15, 2026 25d ago	Insider Cluster NEUTRAL ★ 3/10	$52.07 $53.86	▲ +3.44%	▲ +1.82%	$54.86 (+5.36%)
May 14, 2026 26d ago	144 NEUTRAL ★ 2/10	$52.85 $54.50	▲ +3.12%	▲ +2.16%	$54.86 (+3.80%)
May 6, 2026 4w ago	8-K BULLISH ★ 6/10	$50.72 $51.70	▲ +1.93%	▲ +0.80%	$54.86 (+8.16%)
Apr 17, 2026 7w ago	Press Release NEUTRAL ★ 3/10	$50.00 $49.38	▼ −1.24%	▼ −1.79%	$54.86 (+9.72%)
Apr 15, 2026 7w ago	Press Release NEUTRAL ★ 3/10	$48.48 $49.64	▲ +2.39%	▲ +1.41%	$54.86 (+13.16%)
Apr 10, 2026 8w ago	DEFA14A NEUTRAL ★ 2/10	$48.43 $49.30	▲ +1.80%	▼ −1.50%	$54.86 (+13.28%)
Mar 30, 2026 10w ago	Press Release NEUTRAL ★ 4/10	$46.37 $46.87	▲ +1.08%	▼ −3.22%	$54.86 (+18.31%)

US Market Status

Market Closed — Opens in 6h 58m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access